Lytgobi Disease Interactions
There are 2 disease interactions with Lytgobi (futibatinib).
Futibatinib (applies to Lytgobi) hepatic impairment
Moderate Potential Hazard, Moderate plausibility. Applicable conditions: Liver Disease
The pharmacokinetics of futibatinib has not been studied in patients with moderate or severe hepatic impairment (total bilirubin greater than 1.5 x ULN and any AST).
Futibatinib (applies to Lytgobi) renal dysfunction
Moderate Potential Hazard, Moderate plausibility.
The pharmacokinetics of futibatinib has not been studied in patients with severe renal impairment (CrCl 15 to 29 mL/min), renal dialysis in end-stage renal disease (CrCl less than 15 mL/min).
Switch to professional interaction data
Lytgobi drug interactions
There are 178 drug interactions with Lytgobi (futibatinib).
Lytgobi alcohol/food interactions
There is 1 alcohol/food interaction with Lytgobi (futibatinib).
Report options
More about Lytgobi (futibatinib)
- Lytgobi consumer information
- Check interactions
- Compare alternatives
- Pricing & coupons
- Imprints, shape & color data
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: multikinase inhibitors
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
See also:
Pemazyre
Pemazyre is used to treat certain types of bile duct cancer and myeloid/lymphoid neoplasms ...
Alecensa
Alecensa (alectinib) is an oral kinase inhibitor that may be used to treat certain types of ...
Ozempic
Learn about Ozempic (semaglutide) for type 2 diabetes treatment, weight management, cardiovascular ...
Alunbrig
Alunbrig (brigatinib) is used to treat anaplastic lymphoma kinase-positive (ALK+) metastatic ...
Augtyro
Augtyro (repotrectinib) is a next-generation TKI (Tyrosine Kinase Inhibitor) cancer medicine used ...
Ayvakit
Ayvakit (avapritinib) is a prescription medicine used for the treatment of gastrointestinal stromal ...
Balversa
Balversa (erdafitinib) is an oral kinase inhibitor that may be used to treat adults with locally ...
Braftovi
Braftovi is a targeted cancer treatment used in combination with Mektovi, mFOLFOX6, or Erbitux, to ...
Cabometyx
Cabometyx is used to treat advanced kidney cancer, liver cancer, thyroid cancer, and pancreatic and ...
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.